Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Aberrant expression of hypoxia-inducible factor 1α, TWIST and E-cadherin is associated with aggressive tumor phenotypes in endometrioid endometrial carcinoma.

Feng Z, Gan H, Cai Z, Li N, Yang Z, Lu G, Chen J.

Jpn J Clin Oncol. 2013 Apr;43(4):396-403. doi: 10.1093/jjco/hys237. Epub 2013 Jan 30.

PMID:
23372184
2.

Prognostic implications of epithelial to mesenchymal transition related proteins (E-cadherin, Snail) and hypoxia inducible factor 1α in endometrioid endometrial carcinoma.

Abouhashem NS, Ibrahim DA, Mohamed AM.

Ann Diagn Pathol. 2016 Jun;22:1-11. doi: 10.1016/j.anndiagpath.2016.01.004. Epub 2016 Feb 23.

PMID:
27180053
3.

Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.

Wei L, Sun JJ, Cui YC, Jiang SL, Wang XW, Lv LY, Xie L, Song XR.

Tumour Biol. 2016 Jul;37(7):9979-87. doi: 10.1007/s13277-016-4896-2. Epub 2016 Jan 27.

PMID:
26819207
4.

ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma.

Romero-Pérez L, López-García MÁ, Díaz-Martín J, Biscuola M, Castilla MÁ, Tafe LJ, Garg K, Oliva E, Matias-Guiu X, Soslow RA, Palacios J.

Mod Pathol. 2013 Nov;26(11):1514-24. doi: 10.1038/modpathol.2013.93. Epub 2013 Jun 7.

5.

Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.

Osada R, Horiuchi A, Kikuchi N, Yoshida J, Hayashi A, Ota M, Katsuyama Y, Melillo G, Konishi I.

Hum Pathol. 2007 Sep;38(9):1310-20. Epub 2007 Jun 6. Erratum in: Hum Pathol. 2008 Jan;39(1):147. Mellilo, Giovanni [corrected to Melillo, Giovanni].

PMID:
17555795
6.

Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role.

Espinosa I, José Carnicer M, Catasus L, Canet B, D'angelo E, Zannoni GF, Prat J.

Am J Surg Pathol. 2010 Nov;34(11):1708-14. doi: 10.1097/PAS.0b013e3181f32168.

PMID:
20962622
7.

Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma.

Kim YT, Choi EK, Kim JW, Kim DK, Kim SH, Yang WI.

Yonsei Med J. 2002 Dec;43(6):701-11.

8.

Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma.

Montserrat N, Mozos A, Llobet D, Dolcet X, Pons C, de Herreros AG, Matias-Guiu X, Prat J.

Hum Pathol. 2012 May;43(5):632-43. doi: 10.1016/j.humpath.2011.06.021. Epub 2011 Sep 21.

PMID:
21940036
9.

Hypoxia Induces Epithelial-Mesenchymal Transition in Follicular Thyroid Cancer: Involvement of Regulation of Twist by Hypoxia Inducible Factor-1α.

Yang YJ, Na HJ, Suh MJ, Ban MJ, Byeon HK, Kim WS, Kim JW, Choi EC, Kwon HJ, Chang JW, Koh YW.

Yonsei Med J. 2015 Nov;56(6):1503-14. doi: 10.3349/ymj.2015.56.6.1503.

10.

Activation of STAT3 signal pathway correlates with twist and E-cadherin expression in hepatocellular carcinoma and their clinical significance.

Zhang CH, Xu GL, Jia WD, Li JS, Ma JL, Ren WH, Ge YS, Yu JH, Liu WB, Wang W.

J Surg Res. 2012 May 1;174(1):120-9. doi: 10.1016/j.jss.2010.10.030. Epub 2010 Nov 23.

PMID:
21316706
11.

Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.

Shaco-Levy R, Sharabi S, Benharroch D, Piura B, Sion-Vardy N.

Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):226-32. doi: 10.1016/j.ejogrb.2008.01.004. Epub 2008 Mar 4.

PMID:
18295959
12.

Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma.

Horrée N, Gort EH, van der Groep P, Heintz AP, Vooijs M, van Diest PJ.

J Pathol. 2008 Jan;214(1):38-45.

PMID:
17985331
13.

Prognostic significance of the epithelial-to-mesenchymal transition markers e-cadherin, vimentin and twist in bladder cancer.

Zhao J, Dong D, Sun L, Zhang G, Sun L.

Int Braz J Urol. 2014 Mar-Apr;40(2):179-89. doi: doi: 10.1590/S1677-5538.IBJU.2014.02.07.

14.

E-cadherin and CD10 expression in atypical hyperplastic and malignant endometrial lesions.

Ahmed AR, Muhammad EM.

J Egypt Natl Canc Inst. 2014 Dec;26(4):211-7. doi: 10.1016/j.jnci.2014.08.002. Epub 2014 Oct 2.

15.

Hypoxia-inducible factor 1α-induced epithelial-mesenchymal transition of endometrial epithelial cells may contribute to the development of endometriosis.

Xiong Y, Liu Y, Xiong W, Zhang L, Liu H, Du Y, Li N.

Hum Reprod. 2016 Jun;31(6):1327-38. doi: 10.1093/humrep/dew081. Epub 2016 Apr 19.

PMID:
27094478
16.

Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma.

Sasaki K, Natsugoe S, Ishigami S, Matsumoto M, Okumura H, Setoyama T, Uchikado Y, Kita Y, Tamotsu K, Sakamoto A, Owaki T, Aikou T.

J Exp Clin Cancer Res. 2009 Dec 21;28:158. doi: 10.1186/1756-9966-28-158.

17.

Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.

Sivridis E, Giatromanolaki A, Gatter KC, Harris AL, Koukourakis MI; Tumor and Angiogenesis Research Group.

Cancer. 2002 Sep 1;95(5):1055-63.

18.

Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.

Seeber LM, Horrée N, van der Groep P, van der Wall E, Verheijen RH, van Diest PJ.

BMC Cancer. 2010 Jun 19;10:307. doi: 10.1186/1471-2407-10-307.

19.

Tumor budding and E-Cadherin expression in endometrial carcinoma: are they prognostic factors in endometrial cancer?

Koyuncuoglu M, Okyay E, Saatli B, Olgan S, Akin M, Saygili U.

Gynecol Oncol. 2012 Apr;125(1):208-13. doi: 10.1016/j.ygyno.2011.12.433. Epub 2011 Dec 22.

PMID:
22198340
20.

Slug is a key mediator of hypoxia induced cadherin switch in HNSCC: correlations with poor prognosis.

Zhang J, Cheng Q, Zhou Y, Wang Y, Chen X.

Oral Oncol. 2013 Nov;49(11):1043-50. doi: 10.1016/j.oraloncology.2013.08.003. Epub 2013 Sep 13.

PMID:
24035721

Supplemental Content

Support Center